News
Does BioNTech SE Sponsored ADR (BNTX) have what it takes to be a top stock pick for momentum investors? Let's find out.
Pfizer (PFE) and BioNTech (BNTX) lose bid to appeal a High Court ruling that issued Moderna (MRNA) a COVID-19 vaccine patent ...
Analysts estimate that BioNTech will report an earnings per share (EPS) of $-1.31. The market awaits BioNTech's announcement, ...
Bristol-Myers Squibb sees stabilizing sales, growth in key drugs, and raised guidance. Click to read more about why BMY is an ...
9d
Zacks.com on MSNHas BioNTech (BNTX) Outpaced Other Medical Stocks This Year?Here is how BioNTech SE Sponsored ADR (BNTX) and EUROFINS SCIENT (ERFSF) have performed compared to their sector so far this year.
5d
Zacks.com on MSNShould You Buy, Hold, or Sell BMY Stock Ahead of Q2 Earnings?Detailed price information for Biontech Se ADR (BNTX-Q) from The Globe and Mail including charting and trades.
PFE eyes Q2 earnings beat as strength in Vyndaqel and Padcev is expected to offset declines from Eliquis, Ibrance and Prevnar ...
Detailed price information for Biontech Se ADR (BNTX-Q) from The Globe and Mail including charting and trades.
US mRNA specialist Moderna has announced that the UK Court of Appeal has upheld the validity of its EP'949 patent.
One relatively safe bet about how Pfizer's lineup will look different five years from now is that the company will be a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results